๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Daily granulocyte and monocyte adsorptive apheresis in patients with active ulcerative colitis: a prospective safety and feasibility study

โœ Scribed by Takayuki Yamamoto; Satoru Umegae; Koichi Matsumoto

Publisher
Springer Japan
Year
2011
Tongue
English
Weight
217 KB
Volume
46
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A multi center study of granulocyte and
A multi center study of granulocyte and monocyte adsorption apheresis therapy for ulcerative colitisโ€”Clinical efficacy and production of interleukin-1 receptor antagonist
โœ Hiroaki Takeda; Yasukuni Suzuki; Yuji Takeda; Shoichi Nishise; Tadahisa Fukui; S ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 190 KB

## Abstract Granulocyte and monocyte adsorption apheresis (GCAP) is a useful strategy for intractable ulcerative colitis, but its mechanisms of therapy is not fully explained. Previously, depleting activated granulocytes and monocytes (GMs) and modifying product of proinflammatory cytokines had bee

Optimal apheresis treatment volume for t
Optimal apheresis treatment volume for the efficacy and safety of leukocytapheresis with cellsorba in patients with active ulcerative colitis
โœ Ken Fukunaga; Koji Kamikozuru; Yoko Yokoyama; Nobuyuki Hida; Yoshio Ohda; Naohis ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 165 KB

## Abstract **Background**: Leukocytapheresis (LCAP) is used as an adjunct therapy for patients with active ulcerative colitis (UC). Although, LCAP is routinely performed at 3,000 mL per session, we were interested to see that if this can be replaced with bodyweight (BW) adjusted volume. **Methods*